108 - From heartbeats to chords: advanced chordoma in a background of cardiovascular disease

Autor: Moreno, M, Wall, P, Helmhout, W, Daugherty, H, Guo, Y, Henegan, JC

Publikováno v: In The American Journal of the Medical Sciences February 2024 367 Supplement 1:S61-S62

568 - Evaluating the frequency of adverse events deemed immune-mediated in the placebo arm of double-blind randomized immunotherapy trials to determine how often immune-mediated adverse events are misidentified

Autor: Ganem, PK, Henegan, JC

Publikováno v: In The American Journal of the Medical Sciences February 2023 365 Supplement 1:S309-S310

From heartbeats to chords: advanced chordoma in a background of cardiovascular disease

Autor: Moreno, M, Wall, P, Helmhout, W, Daugherty, H, Guo, Y, Henegan, JC

Publikováno v: The American Journal of the Medical Sciences; February 2024, Vol. 367 Issue: 1, Number 1 Supplement 1 pS61-S62, 2p

Identifying and addressing social health disparities through everscare

Autor: Patel, R, Hitt, M, Ross, W, Buck, W, Reves, P, Henegan, JC, Clark, A

Publikováno v: The American Journal of the Medical Sciences; February 2023, Vol. 365 Issue: 1, Number 1 Supplement 1 pS100-S101, 2p

Marital Status, Living Arrangement, and Survival among Individuals with Advanced Prostate Cancer in the International Registry for Men with Advanced Prostate Cancer.

Autor: Chen N; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts., McGrath CB; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts., Ericsson CI; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts., Vaselkiv JB; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts., Rencsok EM; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.; Harvard-MIT Division of Health Sciences and Technology, Harvard Medical School, Boston, Massachusetts., Stopsack KH; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Guard HE; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts., Autio KA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Rathkopf DE; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Enting D; Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom., Bitting RL; Durham VA Health Care System, Durham, North Carolina., Mateo J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital Campus, Barcelona, Spain., Githiaka CW; Department of Surgery, University of Nairobi, Nairobi, Kenya., Chi KN; BC Cancer, Vancouver, British Columbia, Canada., Cheng HH; University of Washington and Fred Hutchinson Cancer Center, Seattle, Washington., Davis ID; Monash University Faculty of Medicine, Melbourne, Australia.; Eastern Health, Melbourne, Australia., Anderson SG; The Glasgow-Caribbean Centre for Development Research and the Caribbean Institute of Health Research, The University of the West Indies, Bridgetown, Barbados.; African-Caribbean Cancer Consortium, Philadelphia, Pennsylvania., Badal SAM; African-Caribbean Cancer Consortium, Philadelphia, Pennsylvania.; The University of the West Indies Mona, Kingston, Jamaica., Bjartell A; Department of Urology, Skåne University Hospital, Malmö, Sweden., Russnes KM; Department of Oncology, Oslo University Hospital, Oslo, Norway., Heath EI; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan., Pomerantz MM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Henegan JC; Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi., Hyslop T; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania., Esteban E; Department of Medical Oncology, Hospital Universitario Central of Asturias, ISPA, Oviedo, Spain., Omlin A; OnkoZentrum, Zurich, Switzerland., McDermott R; St Vincent's University Hospital and Cancer Trials Ireland, Dublin, Ireland., Fay AP; PUCRS School of Medicine, Hospital Nora Teixeira, Porto Alegre, Brazil., Popoola AA; University of Ilorin, Ilorin, Nigeria., Ragin C; African-Caribbean Cancer Consortium, Philadelphia, Pennsylvania.; Fox Chase Cancer Center, Philadelphia, Pennsylvania., Nowak J; Cancer ABCs, Brooklyn, New York., Gerke T; Prostate Cancer Clinical Trials Consortium, New York, New York., Kantoff PW; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., George DJ; Durham VA Health Care System, Durham, North Carolina., Penney KL; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Mucci LA; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.

Publikováno v: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2024 Mar 01; Vol. 33 (3), pp. 419-425.